Wolverine Trading, LLC Natera, Inc. Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $7,913 - $9,982	79 Added 2.22%	3,630 $391,000
Q2 2021 Aug 06, 2021	SELL	$86.05 - $119.72 $118,576 - $164,974	-1,378 Reduced 27.96%	3,551 $413,000
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $98,238 - $133,562	1,074 Added 27.86%	4,929 $479,000
Q3 2020 Nov 13, 2020	SELL	$45.89 - $72.67 $30,929 - $48,979	-674 Reduced 14.88%	3,855 $280,000
Q2 2020 Aug 13, 2020	SELL	$26.36 - $49.86 $72,990 - $138,062	-2,769 Reduced 37.94%	4,529 $216,000
Q4 2019 Feb 12, 2020	BUY	$32.1 - $40.4 $234,265 - $294,839	7,298 New	7,298 $245,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.